Careers Media center Contacts

Pen-Herpevir®—a new solution to herpes labialis problem

30 July 2019 | News

Arterium Corporation has presented Pen-Herpevir®, a new anti-herpes cream. The product has penciclovir molecule in its composition to effectively target even aciclovir-resistant strains of herpes simplex. The anti-microbial action of Pen-Herpevir® kicks in just 1 minute after application*. Pen-Herpevir® effectively treats all stages of herpes, even after the appearance of papules and blisters. With Pen-Herpevir®, the healing period can be reduced to 4 days. In addition, it reduces pain and quickens exfoliation of scabs formed on the lips during herpes.

*Vere Hodge R. A., Perkins R. M. Mode of action of 9 - (4 hydroxy-3 hydroxymethylbut-1 yl) guanine (BRL 39123) against herpes simplex virus in MRC-5 cells // Antimicrob Agents Chemother. 1989; 33: 223–229.

This information is intended for medical and pharmaceutical personnel only and shall be used only in relevant professional activities. The data given here is abridged. For full information about the medicinal product, refer to its instruction for medical use. This website is a specialized publication intended for medical and pharmaceutical personnel only. Consult a doctor prior to using the drug. Self-medication can be harmful to your health.

Media gallery

Here you can find general information about the company intended for journalists and other stakeholders


For all media-related enquiries,
please contact us
mob.: +38050 446 71 20, +38095 278 92 80